This invention relates to a class of novel dicarboxy amide derivatives of lipophilic amines which exhibit squalene synthase inhibition properties. More specifically the compounds are bis-aryl and/or heteroaryl alkyl or cycloalkylamino dicarboxy amides. Compounds of this invention reduce levels of serum cholesterol in the body without significantly reducing mevalonic metabolite synthesis. This invention relates also to pharmacological compositions and method of treatment for lowering serum cholesterol levels using the compounds of this invention.
                            本发明涉及一类新型的脂溶性胺的二羧酰胺衍
生物,其具有
角鲨烷合酶抑制作用。更具体地说,这些化合物是双芳基和/或杂环芳基烷基或环烷基
氨基二羧酰胺。本发明的化合物可以降低体内的血清
胆固醇水平,而不会显著降低
甲烷代谢产物的合成。本发明还涉及利用本发明的化合物的药理组合物和治疗降低血清
胆固醇水平的方法。